Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on: October 16,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on:October 16,2024

What are the early signs of dementia, and how does it differ from normal aging?

by Lachlan Gilbert,University of New South WalesCredit: Pixabay/CC0 Public DomainForgetting names and misplacing items happen to us all, more so as we age.But when should you be concerned that t

Updated on: March 08,2024

What are the early signs of dementia, and how does it differ from normal aging?

by Lachlan Gilbert,University of New South WalesCredit: Pixabay/CC0 Public DomainForgetting names and misplacing items happen to us all, more so as we age.But when should you be concerned that t

Updated on:March 08,2024

Neural pathway in mice sheds light on how the brain regulates learned immune responses

Updated on: March 09,2025

Neural pathway in mice sheds light on how the brain regulates learned immune responses

Updated on:March 09,2025

Alzheimer's and aducanumab: Unjust profits and false hopes

by The Hastings CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at leas

Updated on: April 08,2024

Alzheimer's and aducanumab: Unjust profits and false hopes

by The Hastings CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at leas

Updated on:April 08,2024

Potassium-enriched salt shows promise for cutting recurrent stroke risk in clinical trial

Updated on: April 09,2025

Potassium-enriched salt shows promise for cutting recurrent stroke risk in clinical trial

Updated on:April 09,2025

Top researchers advocate united actions to fight Alzheimer's disease

by Karolinska InstitutetTo meet the challenge of Alzheimer's disease and other dementias, a concerted effort and long-term economic commitment is needed, according to a new expert report by i

Updated on: February 28,2024

Top researchers advocate united actions to fight Alzheimer's disease

by Karolinska InstitutetTo meet the challenge of Alzheimer's disease and other dementias, a concerted effort and long-term economic commitment is needed, according to a new expert report by i

Updated on:February 28,2024

Dementia care at home: Raising knowledge and confidence to improve quality and decrease costs

by New York UniversityOver two thirds or the home health care population consists of adults over the age of 65, approximately 36% have some form of cognitive impairment, including dementia. Accor

Updated on: February 28,2024

Dementia care at home: Raising knowledge and confidence to improve quality and decrease costs

by New York UniversityOver two thirds or the home health care population consists of adults over the age of 65, approximately 36% have some form of cognitive impairment, including dementia. Accor

Updated on:February 28,2024

First human vagus nerve recordings pinpoint cardiovascular signals

byMonash UniversityCredit:The Journal of Physiology(2024). DOI: 10.1113/JP286423The team that first recorded vagus nerve signals in humans has now isolated the electrical activity of

Updated on: October 14,2024

First human vagus nerve recordings pinpoint cardiovascular signals

byMonash UniversityCredit:The Journal of Physiology(2024). DOI: 10.1113/JP286423The team that first recorded vagus nerve signals in humans has now isolated the electrical activity of

Updated on:October 14,2024

Drop in body temperature linked to aging aggravates manifestations of Alzheimer's disease

by Laval UniversityDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.The drop in body temperature associated with aging could aggravate the main manif

Updated on: February 28,2024

Drop in body temperature linked to aging aggravates manifestations of Alzheimer's disease

by Laval UniversityDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.The drop in body temperature associated with aging could aggravate the main manif

Updated on:February 28,2024

Diabetes drug could influence brain activity in Alzheimer's

by Alzheimer's Research UKResearchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.Thepil

Updated on: February 28,2024

Diabetes drug could influence brain activity in Alzheimer's

by Alzheimer's Research UKResearchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.Thepil

Updated on:February 28,2024

Experimental study in rats and humans show cognitive effort whets the appetite for reward

by PNAS NexusEffects of cognitive effort without rest on cocaine self-administration. Experimental design (A), time course (B) and average in the last 3 days of self-administration (C) of number of in

Updated on: November 07,2024

Experimental study in rats and humans show cognitive effort whets the appetite for reward

by PNAS NexusEffects of cognitive effort without rest on cocaine self-administration. Experimental design (A), time course (B) and average in the last 3 days of self-administration (C) of number of in

Updated on:November 07,2024

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024